Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
41.67
+0.68 (1.66%)
At close: Dec 5, 2025, 4:00 PM EST
42.00
+0.33 (0.79%)
After-hours: Dec 5, 2025, 4:43 PM EST
KNSA Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 3,158 | 1,428 | 1,234 | 1,042 | 811 | 1,203 | |
| Market Cap Growth | 110.11% | 15.76% | 18.45% | 28.46% | -32.59% | 98.17% | |
| Enterprise Value | 2,816 | 1,215 | 1,046 | 848 | 617 | 840 | |
| Last Close Price | 41.67 | 19.78 | 17.54 | 14.98 | 11.77 | 17.67 | |
| PE Ratio | 89.26 | - | 87.60 | 5.68 | - | - | |
| Forward PE | 22.22 | 42.93 | - | - | - | - | |
| PS Ratio | 5.11 | 3.37 | 4.57 | 4.73 | 21.04 | - | |
| PB Ratio | 5.87 | 3.26 | 2.81 | 2.63 | 4.38 | 3.86 | |
| P/TBV Ratio | 6.08 | 3.38 | 2.93 | 2.76 | 4.89 | 3.86 | |
| P/FCF Ratio | 31.05 | 56.20 | 93.67 | 182.67 | - | - | |
| P/OCF Ratio | 30.71 | 55.59 | 92.76 | 179.37 | - | - | |
| EV/Sales Ratio | 4.71 | 2.87 | 3.87 | 3.85 | 16.02 | - | |
| EV/EBITDA Ratio | 71.04 | - | - | 69.62 | - | - | |
| EV/EBIT Ratio | 73.81 | - | - | 86.73 | - | - | |
| EV/FCF Ratio | 27.68 | 47.81 | 79.39 | 148.64 | - | - | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | 0.02 | |
| Debt / EBITDA Ratio | 0.22 | - | - | 0.38 | - | - | |
| Debt / FCF Ratio | 0.10 | 0.39 | 0.93 | 1.04 | - | - | |
| Asset Turnover | 0.94 | 0.77 | 0.55 | 0.64 | 0.13 | - | |
| Inventory Turnover | 8.06 | 6.58 | 3.41 | 3.72 | - | - | |
| Quick Ratio | 3.27 | 2.84 | 3.58 | 4.48 | 4.15 | 10.16 | |
| Current Ratio | 3.85 | 3.30 | 4.34 | 5.16 | 4.38 | 10.46 | |
| Return on Equity (ROE) | 7.39% | -9.85% | 3.37% | 63.10% | -63.55% | -60.07% | |
| Return on Assets (ROA) | 3.76% | -5.15% | -3.19% | 1.76% | -33.63% | -32.57% | |
| Return on Capital (ROIC) | 4.80% | -6.34% | -3.69% | 2.06% | -38.39% | -35.96% | |
| Return on Capital Employed (ROCE) | 6.50% | -9.50% | -5.40% | 2.40% | -83.30% | -49.50% | |
| Earnings Yield | 1.14% | -3.02% | 1.14% | 17.60% | -19.48% | -13.42% | |
| FCF Yield | 3.22% | 1.78% | 1.07% | 0.55% | -15.63% | -11.37% | |
| Buyback Yield / Dilution | -7.99% | 0.69% | -2.13% | -2.69% | -10.89% | -14.42% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.